Abstract
The purpose of this paper is to review current knowledge and provide advice on breastfeeding, formula feeding of term infants (including which type of formula may be appropriate for a given patient), and the timing and composition of complementary feeding. The review is primarily aimed at children living in Europe, generally in an industrialised country. In brief, all infants should be exclusively breastfed from birth to about 6 months (26 weeks) of age or at least for the first 4 months (18 weeks) of life. Breastfeeding should preferably continue beyond the first year of life. Infants who cannot be breastfed, or should not receive breast milk, or for whom breast milk is not available, require breast milk substitutes of high quality. Based on the available evidence, it is reasonable to advise that for all infants, complementary foods should not be given before 17 weeks and should be introduced by 26 weeks; however, no data are available to form evidencebased recommendations. New foods should not be introduced too often – generally not more frequently than every 3 days – nor should more than one new food be introduced at a time.
Keywords: Infant feeding, childhood, infancy, complementary feeding
Current Pediatric Reviews
Title: Nutrition in Infancy
Volume: 3 Issue: 4
Author(s): Hania Szajewska and Andrea Horvath
Affiliation:
Keywords: Infant feeding, childhood, infancy, complementary feeding
Abstract: The purpose of this paper is to review current knowledge and provide advice on breastfeeding, formula feeding of term infants (including which type of formula may be appropriate for a given patient), and the timing and composition of complementary feeding. The review is primarily aimed at children living in Europe, generally in an industrialised country. In brief, all infants should be exclusively breastfed from birth to about 6 months (26 weeks) of age or at least for the first 4 months (18 weeks) of life. Breastfeeding should preferably continue beyond the first year of life. Infants who cannot be breastfed, or should not receive breast milk, or for whom breast milk is not available, require breast milk substitutes of high quality. Based on the available evidence, it is reasonable to advise that for all infants, complementary foods should not be given before 17 weeks and should be introduced by 26 weeks; however, no data are available to form evidencebased recommendations. New foods should not be introduced too often – generally not more frequently than every 3 days – nor should more than one new food be introduced at a time.
Export Options
About this article
Cite this article as:
Szajewska Hania and Horvath Andrea, Nutrition in Infancy, Current Pediatric Reviews 2007; 3(4) . https://dx.doi.org/10.2174/157339607782411529
DOI https://dx.doi.org/10.2174/157339607782411529 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Solutions for the Interception of Quorum Sensing in Staphylococcus aureus
Current Organic Chemistry Myocardial Infarction in Systemic Lupus Erythematosus – the Sex-Specific Risk Profile
Current Pharmaceutical Design New Treatments for Emerging Cystic Fibrosis Pathogens other than Pseudomonas
Current Pharmaceutical Design Invasive Aspergillosis: New Insights into Disease, Diagnostic and Treatment
Current Pharmaceutical Design The Entirely Subcutaneous Defibrillator (S-Icd): State of the Art and Selection of the Ideal Candidate
Current Cardiology Reviews Antimicrobial Peptides and Peptidomimetics - Potent Therapeutic Allies for Staphylococcal Infections
Current Pharmaceutical Design Linezolid in Children: Recent Patents and Advances
Recent Patents on Anti-Infective Drug Discovery Reviewing the Cardiovascular Complications of HIV Infection After the Introduction of Highly Active Antiretroviral Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Macrolides Allergy
Current Pharmaceutical Design An Update to Enterococcal Bacteremia: Epidemiology, Resistance, and Outcome
Infectious Disorders - Drug Targets Combined Brain/Heart Magnetic Resonance Imaging in Systemic Lupus Erythematosus
Current Cardiology Reviews Immunoinformatic Approach for the Identification of Potential Epitopes Against <i>Stenotrophomonas maltophilia</i>: A Global Opportunistic Pathogen
Letters in Drug Design & Discovery Synthesis and Antimicrobial Evaluation of (Z)-5-((3-phenyl-1H-pyrazol-4- yl)methylene)-2-thioxothiazolidin-4-one Derivatives
Medicinal Chemistry Computational Modelling of Catalytic Properties and Modified Substrates of Fungal β-N-Acetylhexosaminidases
Mini-Reviews in Organic Chemistry Assay of Daptomycin Injection: Development and Validation of an Environment-friendly CZE Method
Current Pharmaceutical Analysis Dealing with the Substance Abuse Epidemic and Infective Endocarditis:Clinical, Immunologic and Pathogenetic Aspects
Current Vascular Pharmacology Drug Interactions During Periodontal Therapy in HIV-Infected Subjects
Mini-Reviews in Medicinal Chemistry The Rise of Carbapenem-Resistant Acinetobacter baumannii
Current Pharmaceutical Design Best Practice for Atrial Fibrillation Patient Education
Current Pharmaceutical Design Antithrombotic Therapy in Cardiac Embolism
Current Cardiology Reviews